- Telehealth visits
Nicole Ling, MD
Rheumatology • Pediatric Rheumatology- Telehealth visits
Nicole Ling, MD
Rheumatology • Pediatric Rheumatology- Telehealth visits
On this page
About me
Dr. Nicole Ling is a pediatric rheumatologist who specializes in caring for children and adolescents with diseases such as juvenile idiopathic arthritis, lupus, vasculitis, juvenile dermatomyositis and scleroderma. In addition to patient care, she works with the Benioff Children's Hospital's quality improvement executive committee and is developing quality improvement metrics for outpatient care in pediatric subspecialties at UCSF. She also co-chairs the medication safety subcommittee.
Ling earned her medical degree from the University of California, Davis School of Medicine. She completed her residency in pediatrics at UCSF Benioff Children's Hospital Oakland, followed by a fellowship in pediatric rheumatology at UCSF.
Ling is a member of the American College of Rheumatology and Childhood Arthritis and Rheumatology Research Alliance.
Education & training
Board certification
- Pediatric Rheumatology, American Board of Pediatrics
- Pediatrics, American Board of Pediatrics
Fellowship
- Pediatric Rheumatology, UCSF Medical Center GME/RESEARCH
Residency
- Pediatrics, Childrens Hospital and Medical Center - GME
Internship
- Pediatrics, Childrens Hospital and Medical Center - GME
Degree
- MD, University of California-Davis School of Medicine
Academic Title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.